Document is current
Any future updates will be listed below
-
Authors
Rucker-Joerg, Isabel E.
Cardona-Muñoz, Ernesto G. https://orcid.org/0000-0001-7868-667X
Padilla-Padilla, Francisco G. https://orcid.org/0000-0002-5900-2284
Suarez-Otero, Rodrigo https://orcid.org/0000-0002-3046-2973
Romero-Antonio, Yulia https://orcid.org/0000-0003-2613-1714
Canales-Vázquez, Emmanuel https://orcid.org/0009-0000-4954-0292
Rios-Brito, Kevin F. https://orcid.org/0009-0003-7012-3831
Rodríguez-Vazquez, Ileana C. https://orcid.org/0000-0001-8578-3742
González-Canudas, Jorge https://orcid.org/0000-0001-7412-6499
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04927299 at ClinicalTrials.govDocuments that mention this clinical trial
Optimizing Blood Pressure Control: A Randomized Comparative Trial of Losartan/Chlorthalidone vs. Losartan/Hydrochlorothiazide
https://doi.org/10.1007/s40119-025-00407-7
- License Information
-
More Information
Article History
Received: 18 February 2025
Accepted: 28 March 2025
First Online: 24 April 2025
Declarations
:
: Isabel E. Rucker-Joerg, Ernesto G. Cardona-Muñoz, Francisco G. Padilla-Padilla, and Rodrigo Suarez-Otero confirm that they have no conflicts of interest to declare. Jorge Alejandro Gonzalez Canudas, Emmanuel Canales-Vázquez, Yulia Romero-Antonio, Kevin F. Rios-Brito, and Ileana Cristina Rodriguez Vazquez are employees of Laboratorios Silanes.
: This study was carried out entirely in accordance with the legal provisions of the General Health Law of the United Mexican States and with the ethical principles emanating from the eighteenth World Medical Assembly in Helsinki, Finland, in 1964 and its respective amendments, concerning medical research on human beings. It was approved by the Research Ethics Committee of Investigación Biomédica para el Desarrollo de Fármacos S.A. de C.V. (Protocol approval number: CEI-000002). Study regulatory adherence: Ministry of Health in Mexico: Federal Commission for the Protection against Sanitary Risks (COFEPRIS) Approval Number: 223300410A0096/2021.
